GlassScriptPhysician profile
Brian J Keyashian
NPI 1962776245
$17,534.23
in general payments reported to CMS, 2019-2025
16 companies · $833 in 2025
The $833 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,635 · 2020: $337 · 2021: $759 · 2022: $11K · 2023: $2,469 · 2024: $850 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,419 · Travel and Lodging: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,418.53 |
| Travel and Lodging | $733.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,136.71 | 2021-2025 | Ellipsys Vascular Access System, Venaseal, In.Pact Admiral |
| Silk Road Medical, INC. | $1,275.62 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Philips North America LLC | $1,027.74 | 2022-2025 | Labosys, (Az7) Lasers, (9281) Turbo Elite |
| Medtronic Vascular, INC. | $565.81 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $425.98 | 2019-2024 | Fluency Endovascular Stent Graft |
| Abbott Laboratories | $321.53 | 2020-2023 | Jeti Peripheral Catheter |
| Shockwave Medical, INC | $285.80 | 2020-2022 | |
| Boston Scientific Corporation | $251.64 | 2023-2025 | Eluvia, General - Vascular Intervention |
| Medela LLC | $59.86 | 2020 | |
| Abbvie INC. | $33.33 | 2023 | |
| Getinge USA Sales, LLC | $31.02 | 2020 | |
| Terumo Medical Corporation | $30.29 | 2024 | |
| Cardiovascular Systems INC. | $28.49 | 2019 | |
| W. L. Gore & Associates, INC. | $22.63 | 2019 | |
| Tactile Systems Technology INC | $19.60 | 2025 | Flexitouch Plus, Nimbl |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Keyashian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.